APO Research
Talk to an analyst

APO RESEARCH · REPORT

Generic Nifedipine Controlled-release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Generic Nifedipine Controlled-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025186 pages

Choose your research edition.

Industry ResearchGeneric Nifedipine Controlled-release Tablets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Generic Nifedipine Controlled-release Tablets Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Generic Nifedipine Controlled-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Generic Nifedipine Controlled-release Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Generic Nifedipine Controlled-release Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Generic Nifedipine Controlled-release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Generic Nifedipine Controlled-release Tablets include Simcere, Shanghai Shyndec Pharma, Qingdao Baiyang Pharmaceutical, Hefei Cube Pharma, Nanjing Easeheal Pharma, Deyao Pharma, CR DOUBLE-CRANE, Beijing Honglin Pharma and Apichope, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Generic Nifedipine Controlled-release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Generic Nifedipine Controlled-release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Generic Nifedipine Controlled-release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Generic Nifedipine Controlled-release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Generic Nifedipine Controlled-release Tablets Segment by Company

Simcere

Shanghai Shyndec Pharma

Qingdao Baiyang Pharmaceutical

Hefei Cube Pharma

Nanjing Easeheal Pharma

Deyao Pharma

CR DOUBLE-CRANE

Beijing Honglin Pharma

Apichope

Generic Nifedipine Controlled-release Tablets Segment by Type

30mg per Tablet

60mg per Tablet

Generic Nifedipine Controlled-release Tablets Segment by Application

Hypertension

Exertional Angina

Other

Generic Nifedipine Controlled-release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Nifedipine Controlled-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Generic Nifedipine Controlled-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Nifedipine Controlled-release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Generic Nifedipine Controlled-release Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Generic Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Generic Nifedipine Controlled-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Generic Nifedipine Controlled-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Generic Nifedipine Controlled-release Tablets Industry Trends Table 2. Generic Nifedipine Controlled-release Tablets Industry Drivers Table 3. Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges Table 4. Generic Nifedipine Controlled-release Tablets Industry Restraints Table 5. Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Generic Nifedipine Controlled-release Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers Table 9. Global Generic Nifedipine Controlled-release Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Generic Nifedipine Controlled-release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Generic Nifedipine Controlled-release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Generic Nifedipine Controlled-release Tablets Manufacturers, Product Type & Application Table 13. Global Generic Nifedipine Controlled-release Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Generic Nifedipine Controlled-release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 30mg per Tablet Table 17. Major Manufacturers of 60mg per Tablet Table 18. Global Generic Nifedipine Controlled-release Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Generic Nifedipine Controlled-release Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2026) Table 22. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2027-2032) Table 23. Global Generic Nifedipine Controlled-release Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hypertension Table 29. Major Manufacturers of Exertional Angina Table 30. Major Manufacturers of Other Table 31. Global Generic Nifedipine Controlled-release Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Generic Nifedipine Controlled-release Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2026) Table 35. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2027-2032) Table 36. Global Generic Nifedipine Controlled-release Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021-2026) Table 44. Global Generic Nifedipine Controlled-release Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Generic Nifedipine Controlled-release Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Generic Nifedipine Controlled-release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2027-2032) Table 63. Simcere Company Information Table 64. Simcere Business Overview Table 65. Simcere Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio Table 67. Simcere Recent Development Table 68. Shanghai Shyndec Pharma Company Information Table 69. Shanghai Shyndec Pharma Business Overview Table 70. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 72. Shanghai Shyndec Pharma Recent Development Table 73. Qingdao Baiyang Pharmaceutical Company Information Table 74. Qingdao Baiyang Pharmaceutical Business Overview Table 75. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio Table 77. Qingdao Baiyang Pharmaceutical Recent Development Table 78. Hefei Cube Pharma Company Information Table 79. Hefei Cube Pharma Business Overview Table 80. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 82. Hefei Cube Pharma Recent Development Table 83. Nanjing Easeheal Pharma Company Information Table 84. Nanjing Easeheal Pharma Business Overview Table 85. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 87. Nanjing Easeheal Pharma Recent Development Table 88. Deyao Pharma Company Information Table 89. Deyao Pharma Business Overview Table 90. Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 92. Deyao Pharma Recent Development Table 93. CR DOUBLE-CRANE Company Information Table 94. CR DOUBLE-CRANE Business Overview Table 95. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio Table 97. CR DOUBLE-CRANE Recent Development Table 98. Beijing Honglin Pharma Company Information Table 99. Beijing Honglin Pharma Business Overview Table 100. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio Table 102. Beijing Honglin Pharma Recent Development Table 103. Apichope Company Information Table 104. Apichope Business Overview Table 105. Apichope Generic Nifedipine Controlled-release Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio Table 107. Apichope Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Generic Nifedipine Controlled-release Tablets Distributors List Table 111. Generic Nifedipine Controlled-release Tablets Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Generic Nifedipine Controlled-release Tablets Product Image Figure 2. Global Generic Nifedipine Controlled-release Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Generic Nifedipine Controlled-release Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Generic Nifedipine Controlled-release Tablets Sales (2021-2032) & (K Units) Figure 5. Global Generic Nifedipine Controlled-release Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Generic Nifedipine Controlled-release Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 30mg per Tablet Image Figure 9. 60mg per Tablet Image Figure 10. Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Generic Nifedipine Controlled-release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hypertension Image Figure 17. Exertional Angina Image Figure 18. Other Image Figure 19. Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Generic Nifedipine Controlled-release Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021-2032) Figure 39. China Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Generic Nifedipine Controlled-release Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Generic Nifedipine Controlled-release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Generic Nifedipine Controlled-release Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Generic Nifedipine Controlled-release Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg per Tablet
  • 60mg per Tablet
Applications
  • Hypertension
  • Exertional Angina
  • Other
Companies covered
  • Simcere
  • Shanghai Shyndec Pharma
  • Qingdao Baiyang Pharmaceutical
  • Hefei Cube Pharma
  • Nanjing Easeheal Pharma
  • Deyao Pharma
  • CR DOUBLE-CRANE
  • Beijing Honglin Pharma
  • Apichope

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Generic Nifedipine Controlled-release Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Generic Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Generic Nifedipine Controlled-release Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Generic Nifedipine Controlled-release Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Generic Nifedipine Controlled-release Tablets Market Dynamics
  1. 2.1 Generic Nifedipine Controlled-release Tablets Industry Trends
  2. 2.2 Generic Nifedipine Controlled-release Tablets Industry Drivers
  3. 2.3 Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges
  4. 2.4 Generic Nifedipine Controlled-release Tablets Industry Restraints
3 Generic Nifedipine Controlled-release Tablets Market by Manufacturers
  1. 3.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Generic Nifedipine Controlled-release Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Generic Nifedipine Controlled-release Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Generic Nifedipine Controlled-release Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Generic Nifedipine Controlled-release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Generic Nifedipine Controlled-release Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Generic Nifedipine Controlled-release Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Generic Nifedipine Controlled-release Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Generic Nifedipine Controlled-release Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Generic Nifedipine Controlled-release Tablets Tier 1, Tier 2, and Tier 3
4 Generic Nifedipine Controlled-release Tablets Market by Type
  1. 4.1 Generic Nifedipine Controlled-release Tablets Type Introduction
  2. 4.1.1 30mg per Tablet
  3. 4.1.2 60mg per Tablet
  4. 4.2 Global Generic Nifedipine Controlled-release Tablets Sales by Type
  5. 4.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Type
  9. 4.3.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2032)
5 Generic Nifedipine Controlled-release Tablets Market by Application
  1. 5.1 Generic Nifedipine Controlled-release Tablets Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Exertional Angina
  4. 5.1.3 Other
  5. 5.2 Global Generic Nifedipine Controlled-release Tablets Sales by Application
  6. 5.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Application
  10. 5.3.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2032)
6 Global Generic Nifedipine Controlled-release Tablets Sales by Region
  1. 6.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Generic Nifedipine Controlled-release Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Generic Nifedipine Controlled-release Tablets Revenue by Region
  1. 7.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Region
  2. 7.1.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Generic Nifedipine Controlled-release Tablets Revenue (2021-2032)
  8. 7.2.2 North America Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Generic Nifedipine Controlled-release Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Generic Nifedipine Controlled-release Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Simcere
  2. 8.1.1 Simcere Company Information
  3. 8.1.2 Simcere Business Overview
  4. 8.1.3 Simcere Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio
  6. 8.1.5 Simcere Recent Developments
  7. 8.2 Shanghai Shyndec Pharma
  8. 8.2.1 Shanghai Shyndec Pharma Company Information
  9. 8.2.2 Shanghai Shyndec Pharma Business Overview
  10. 8.2.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  12. 8.2.5 Shanghai Shyndec Pharma Recent Developments
  13. 8.3 Qingdao Baiyang Pharmaceutical
  14. 8.3.1 Qingdao Baiyang Pharmaceutical Company Information
  15. 8.3.2 Qingdao Baiyang Pharmaceutical Business Overview
  16. 8.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio
  18. 8.3.5 Qingdao Baiyang Pharmaceutical Recent Developments
  19. 8.4 Hefei Cube Pharma
  20. 8.4.1 Hefei Cube Pharma Company Information
  21. 8.4.2 Hefei Cube Pharma Business Overview
  22. 8.4.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  24. 8.4.5 Hefei Cube Pharma Recent Developments
  25. 8.5 Nanjing Easeheal Pharma
  26. 8.5.1 Nanjing Easeheal Pharma Company Information
  27. 8.5.2 Nanjing Easeheal Pharma Business Overview
  28. 8.5.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  30. 8.5.5 Nanjing Easeheal Pharma Recent Developments
  31. 8.6 Deyao Pharma
  32. 8.6.1 Deyao Pharma Company Information
  33. 8.6.2 Deyao Pharma Business Overview
  34. 8.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  36. 8.6.5 Deyao Pharma Recent Developments
  37. 8.7 CR DOUBLE-CRANE
  38. 8.7.1 CR DOUBLE-CRANE Company Information
  39. 8.7.2 CR DOUBLE-CRANE Business Overview
  40. 8.7.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio
  42. 8.7.5 CR DOUBLE-CRANE Recent Developments
  43. 8.8 Beijing Honglin Pharma
  44. 8.8.1 Beijing Honglin Pharma Company Information
  45. 8.8.2 Beijing Honglin Pharma Business Overview
  46. 8.8.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
  48. 8.8.5 Beijing Honglin Pharma Recent Developments
  49. 8.9 Apichope
  50. 8.9.1 Apichope Company Information
  51. 8.9.2 Apichope Business Overview
  52. 8.9.3 Apichope Generic Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio
  54. 8.9.5 Apichope Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Generic Nifedipine Controlled-release Tablets Value Chain Analysis
  2. 9.1.1 Generic Nifedipine Controlled-release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Generic Nifedipine Controlled-release Tablets Production Mode & Process
  6. 9.2 Generic Nifedipine Controlled-release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Generic Nifedipine Controlled-release Tablets Distributors
  9. 9.2.3 Generic Nifedipine Controlled-release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst